Vironika, LLC, is a drug discovery company dedicated to developing novel drugs to block deadly tumor viruses from forming cancers. Unlike any other existing treatments, Vironikas technology platform include proprietary small molecule inhibitors that target viral proteins which will eliminate tumor viruses in their latent hidden forms. Of Focus are (1) Epstein-Barr Virus is a cancer causing virus in the herpes family and and is one of the most common viruses in humans. Occuring worldwide -known to cause infectious mononucleosis and is causes a number of cancer including Burkitt's Lymphoma and Nasopharageal carcinoma. In addition, EBV is suspected to have a role in the pathogenesis of Multiple Sclerosis and other autoimmune diseases. (2) Herpes Simplex Virus, infects over 80% of the adult population worldwide and there is currently no cure. Belongs to the herpes family of viruses: two strains, HSV1 and HSV2. HSV-1 causes encephalitis, corneal blindness (herpes keratitis), and various peripheral nervous system disorders; HSV-2 can cause meningitis and is the primary source of genital herpes. HSV1 and HSV2 establish long-term latent infection in the sensory neurons of the trigeminal or dorsal root ganglions, and frequently reactivate causing complications. There is growing evidence for a role of HSV1 in neurodegenerative diseases such as Alzheimers Disease.
